H. LeRoux Jooste

TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ.

PreCision Dermatology, Inc. developed skincare therapies. It offered pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company was founded by Jeffrey M. Nugent in 2010 and was headquartered in Cumberland, RI.

Children's Hospital Corp. engages in the provision of pediatric care services. It offers acupuncture, angioplasty, antibiotic allergy testing, audiogram, baclofen pump, biochemical genetic testing, blended diet, bone scan, brain scan, breast augmentation surgery, cardiac catheterization, cardiac MRI in children, chest reconstruction surgery, and CO2 laser treatment. The company was founded by Francis Henry Brown in 1869 and is headquartered in Boston, MA.

Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL.

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut.

Part of Astellas Pharma, Inc., Astellas US LLC is a company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa.

KensaGroup LLC (KensaGroup) is a private equity firm founded in 1999 by Bruce Ganem and Tony R. Eisenhut. The firm is headquartered in Ithaca, New York.

Onset Dermatologics LLC develops and markets prescription product for skin disorders. The company was founded in 2005 and is headquartered in Cumberland, RI.

David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA.

Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France.

Luminopia, Inc. operates virtual reality content platform, which treats lazy eye. The company was founded by Scott Xiao, Alex Wendland and Dean A. Travers in and is headquartered in Aspen, CO.

Epibone, Inc. develops bone reconstruction solutions. Its technology utilizes a scan of the patient?s bone defect and the patient?s own stem cells to construct and cultivate an autologous-like bone graft that provides defect repair, and improves bone formation and regeneration. The company was founded by Nina Tandon, Gordana Vunjak-Novakovic, Sarindr Bhumiratana, Sidney Eisig, and Elisa Cimetta and is headquartered in Brooklyn, NY.

aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel.

Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA.

LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA.

Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford.

Celero Systems, Inc. is a life science company. It develops ingestible system to detect and reverse opioid overdose. The company was founded by Benjamin D. Pless, Carlo Giovanni Traverso, Robert S. Langer Jr., and Jeremy N. Ruskin and is headquartered in Lincoln, MA.

Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation.

Xenter, Inc. is a privately held, investor-backed company that has launched a wireless techmed ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients. Xenter is headquartered in Draper, UT and was formed in 2020. The company's trademarks include xenter, xenfi, xmd, xenfi-hub, xmd, and physical intelligence. The company was founded by Richard J. Linder and he has been the CEO since incorporation.

NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021.

Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet.

Syntis Bio, Inc. is a company that creates simple oral therapies and treatments targeting specific tissues through novel formulations. The company is based in Milton, MA. Rahul scaled the company by building a diverse and accomplished team to reach commercialization of the first-ever CRISPR product, diagnostic or therapeutic, to be authorized by the FDA. The company is committed to equity, excellence, and diversity, and is building a culture that supports its team to grow, take risks, and achieve individual goals. It was founded by Carlo Giovanni Traverso, Robert S. Langer, and Rahul K. Dhanda, who has been the CEO since incorporation.